ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
수의 종양학 시장 규모는 2025년 8억 4,000만 달러에서 2034년에는 23억 8,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 12.22%로 성장할 전망입니다.
반려동물의 건강에 대한 인식이 높아지고 동물의 암 발병률이 증가함에 따라 수의 종양학 시장은 견조한 성장세를 보이고 있습니다. 반려동물 보호자들이 사랑하는 반려동물을 위해 첨단 치료법을 찾는 경향이 높아지면서 수의 종양학 서비스 및 제품에 대한 수요가 증가하고 있습니다. 반려동물의 건강에 대한 관심 증가와 수의학의 발전은 동물의 암 치료를 위한 혁신적인 치료법과 진단 도구의 개발을 촉진하고 있습니다. 수의 의료현장에서 종양환자에 대한 전문적인 치료를 우선시함에 따라 수의 종양학 시장은 더욱 발전할 것으로 예상됩니다.
기술 혁신은 수의 종양학 시장의 향후 전망을 형성하는 데 중요한 역할을 하고 있습니다. MRI, CT 스캔 등 영상 진단 기술의 혁신으로 반려동물의 종양 발견 및 경과 관찰 능력이 향상되어 보다 빠르고 정확한 진단이 가능해졌습니다. 또한, 표적치료와 면역치료의 개발은 수의학에서 암 치료에 혁명을 가져왔으며, 반려동물 보호자에게 보다 효과적이고 덜 침습적인 치료법을 제공하고 있습니다. 제조업체와 수의학 전문가들이 조사개발을 위해 협력하는 가운데, 수의 종양학 시장에서는 첨단 치료법과 기술의 채택이 더욱 확대될 것으로 예상됩니다.
또한, 맞춤형 의료와 반려동물 관리에 대한 총체적 접근에 대한 관심이 높아지면서 수의 종양학 시장에도 영향을 미치고 있습니다. 반려동물 보호자들이 반려동물의 건강에 대한 지식이 높아짐에 따라, 환자 개개인의 필요와 희망을 고려한 맞춤형 치료 계획에 대한 수요가 증가하고 있습니다. 이러한 추세는 전통적인 치료법과 영양관리, 통증관리 등 보완요법을 결합한 통합 종양학 서비스의 개발을 촉진하고 있습니다. 시장이 계속 진화하는 가운데, 기술, 개별화된 치료, 그리고 전체론적 접근의 통합은 수의 종양학 분야에서 성공을 위한 중요한 원동력이 될 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 수의 종양학 시장 : 동물 유형별
제5장 세계의 수의 종양학 시장 : 치료법별
제6장 세계의 수의 종양학 시장 : 투여 경로별
제7장 세계의 수의 종양학 시장 : 용도별
제8장 세계의 수의 종양학 시장 : 유통 채널별
제9장 세계의 수의 종양학 시장 : 지역별
제10장 경쟁 구도
제11장 기업 개요
KSM
영문 목차
영문목차
The Veterinary Oncology Market size is expected to reach USD 2.38 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 12.22% during 2026-2034.
The Veterinary Oncology Market is experiencing robust growth as the awareness of pet health and the prevalence of cancer in animals continue to rise. As pet owners increasingly seek advanced treatment options for their beloved companions, the demand for veterinary oncology services and products is expanding. The growing focus on pet wellness, coupled with advancements in veterinary medicine, is driving the development of innovative therapies and diagnostic tools for cancer treatment in animals. As veterinary practices prioritize specialized care for oncology patients, the market for veterinary oncology is expected to flourish.
Technological advancements are playing a crucial role in shaping the future of the veterinary oncology market. Innovations in diagnostic imaging, such as MRI and CT scans, are enhancing the ability to detect and monitor tumors in pets, leading to earlier and more accurate diagnoses. Additionally, the development of targeted therapies and immunotherapies is revolutionizing cancer treatment in veterinary medicine, offering more effective and less invasive options for pet owners. As manufacturers and veterinary professionals continue to collaborate on research and development, the veterinary oncology market is likely to see increased adoption of advanced treatment modalities and technologies.
Moreover, the growing emphasis on personalized medicine and holistic approaches to pet care is influencing the veterinary oncology market. As pet owners become more informed about their pets' health, there is a rising demand for tailored treatment plans that consider individual patient needs and preferences. This trend is driving the development of integrative oncology services that combine conventional treatments with complementary therapies, such as nutrition and pain management. As the market continues to evolve, the integration of technology, personalized care, and holistic approaches will be key drivers of success in the veterinary oncology sector.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Animal Type
Companion Animal (Equine, Canine, and Feline)
Livestock Animal
By Therapy Type
Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy
By Mode of Administration
Oral
Intravenous
By Application
Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Others
By Distribution Channel
Hospital Pharmacies
Government Agencies
Retail Pharmacies
COMPANIES PROFILED
Zoetis Inc, Elanco, Boehringer Ingelheim International GmbH, Merck Animal Health, Varian Medical Systems, Accuray Incorporated, PetCure Oncology, AB Science, Karyopharm Therapeutics Inc, Regeneus Ltd, Morphogenesis Inc, VetDC, Zenoaq, Rhizen Pharmaceutical SA, AdvaVet Inc
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL VETERINARY ONCOLOGY MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Animal Type
4.2. Companion Animal (Equine, Canine, and Feline) Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Livestock Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL VETERINARY ONCOLOGY MARKET: BY THERAPY TYPE 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Therapy Type
5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Combination Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Targeted Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL VETERINARY ONCOLOGY MARKET: BY MODE OF ADMINISTRATION 2022-2034 (USD MN)
6.1. Market Analysis, Insights and Forecast Mode Of Administration
6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL VETERINARY ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)
7.1. Market Analysis, Insights and Forecast Application
7.2. Canine Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Osteosarcoma (OSA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Mast Cell Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Melanoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL VETERINARY ONCOLOGY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
8.1. Market Analysis, Insights and Forecast Distribution Channel
8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Government Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 9. GLOBAL VETERINARY ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)
9.1. Regional Outlook
9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
9.2.1 By Animal Type
9.2.2 By Therapy Type
9.2.3 By Mode Of Administration
9.2.4 By Application
9.2.5 By Distribution Channel
9.2.6 United States
9.2.7 Canada
9.2.8 Mexico
9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
9.3.1 By Animal Type
9.3.2 By Therapy Type
9.3.3 By Mode Of Administration
9.3.4 By Application
9.3.5 By Distribution Channel
9.3.6 United Kingdom
9.3.7 France
9.3.8 Germany
9.3.9 Italy
9.3.10 Russia
9.3.11 Rest Of Europe
9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
9.4.1 By Animal Type
9.4.2 By Therapy Type
9.4.3 By Mode Of Administration
9.4.4 By Application
9.4.5 By Distribution Channel
9.4.6 India
9.4.7 Japan
9.4.8 South Korea
9.4.9 Australia
9.4.10 South East Asia
9.4.11 Rest Of Asia Pacific
9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
9.5.1 By Animal Type
9.5.2 By Therapy Type
9.5.3 By Mode Of Administration
9.5.4 By Application
9.5.5 By Distribution Channel
9.5.6 Brazil
9.5.7 Argentina
9.5.8 Peru
9.5.9 Chile
9.5.10 South East Asia
9.5.11 Rest of Latin America
9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
9.6.1 By Animal Type
9.6.2 By Therapy Type
9.6.3 By Mode Of Administration
9.6.4 By Application
9.6.5 By Distribution Channel
9.6.6 Saudi Arabia
9.6.7 UAE
9.6.8 Israel
9.6.9 South Africa
9.6.10 Rest of the Middle East And Africa
Chapter 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments
10.2. Company Categorization
10.3. Supply Chain & Channel Partners (based on availability)
10.4. Market Share & Positioning Analysis (based on availability)
10.5. Vendor Landscape (based on availability)
10.6. Strategy Mapping
Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY ONCOLOGY INDUSTRY
